Gcp-Service International West GmbH

6 trials 2 recruiting Commercial sponsor

Filter these 6 trials by condition, phase, country and more.

Open in Search →

6 Registered trials

2 Recruiting

3 Completed trials

5 Countries active

8 Unique IMPs

100% Results reported

Phase II

100%

3 of 3 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top IMPs

IMETELSTAT SODIUM 2 7,8-DIBROMO-5,6-DIHYDRO-9-METHYL-2-(1-PIPERAZINYL)-4H-IMIDAZO[4,5,1-IJ]QUINOLINE HYDROCHLORIDE 1 ASCORBIC ACID 1 GLYCEROL, HIGHLY REFINED FISH OIL, PURIFIED EGG PHOSPHOLIPIDS 1 TAGRAXOFUSP 1 VENETOCLAX 1

All trials

6 total

A phase II study evaluating the efficacy and safety of IMetelstat in Patients with HR myElodysplastic SyndromeS or AML failing HMA-based the… Not authorised

2022-500721-32-00 Phase II 2 countries IMETELSTAT SODIUM
A study with three treatments for higher-risk chronic myelomonocytic leukaemia. Recruiting

2024-511102-22-00 Phase II 3 countries TAGRAXOFUSP; VENETOCLAX
Intravenous Fish Oil based Lipid Emulsion to enhance recovery in High-Risk Cardiac Surgery Patients: a phase II multicenter trial Recruiting

2023-503490-38-00 Phase II 1 country GLYCEROL, HIGHLY REFINED FISH OIL, PURIFIED EGG PHOSPHOLIPIDS
Antioxidant Treatment with Vitamin C in Cardiac Surgery Patients - A Pilot Randomized Controlled Trial Ended

2023-510561-10-00 Phase II 1 country ASCORBIC ACID
A phase II, open-label, multicenter study of orally administered RVU120 for the treatment of anemia in patients with lower-risk myelodysplas… Ended

2023-509947-29-00 Phase II 5 countries 7,8-DIBROMO-5,6-DIHYDRO-9-METHYL-2-(1-PIPERAZINYL)-4H-IMIDAZO[4,5,1-IJ]QUINOLINE…
A phase II study evaluating the efficacy and safety of IMetelstat in Patients with HR myElodysplastic SyndromeS or AML failing HMA-based the… Ended

2022-500721-32-01 Phase II 2 countries IMETELSTAT SODIUM

Showing 1–6 of 6 trials

← All sponsors A–Z